FDA Investigator Christina Capacci Daniel, PhD
Christina Capacci Daniel, PhD has inspections in 6 countries as of 13 Oct 2023. Christina Capacci Daniel, PhD has collaborated with a combinined 2944 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Austria,
Germany,
United States of America,
Ireland,
Switzerland,
Taiwan
Co-Investigator(s):
Aimee Cunningham, PhD,
Amy Devlin, PhD,
Angelica M Hernandez,
Anissa M Cheung,
Anna M Brannen,
Anthony C Warchut,
Arie C Menachem,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arthur T Ogdahl,
Arwa S El Hagrasy,
Bethany L Subel,
Binh T Nguyen,
Bogdan Kurtyka,
Brenda P King,
Brentley S Collins,
Brently S Collins,
Bruce H Mccullough,
Burnell M Henry,
Byeongtaek Oh,
Camerson E Moore,
Caryn M Mcnab,
Celia N Cruz,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christopher Downey, PhD,
Christopher T Middendorf,
Craig T Rybus,
Cynthia T Cain,
Darin S Wiegers,
Dawn M Braswell,
Dennis Cantellops Paite,
Donna Christner,
Douglas C Kovacs,
Douglas Florentino,
Dr. Chunchang Fang,
Edmund F Mrak, Jr,
Ekaterina Allen,
Elizabeth Ll Edwards,
Ellen P Madigan,
Emilie E Kahn,
Emily J Orban,
Francis A Guidry,
Gene D Arcy,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
James L Dunnie, Jr,
Jee Chung, PhD,
Jennifer M Gogley,
Joan A Loreng,
Jon P Antoniou,
Jorge L Guadalupe,
Jose A Moreno,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose Velez,
Joshua P Wireman,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Justine M Corson,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kenneth E Felkley,
Kenneth H Williams,
Kumar G Janoria,
Lauren N Howard,
Lauren N Smith,
Laurimer Kuilan Torres,
LCDR Chad N Thompson,
LCDR Debra Emerson,
Libia M Lugo,
Lindsey M Schwierjobann,
Lindsey M Schwierjohann,
Lisa M Lopez,
Logan T Williams,
Luis M Burgos,
Luis M Burgos Medero,
Marianne Allen,
Mark E Parmon,
Martha T Olone,
Marvin D Jones,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Michael A Charles,
Michael P Sheehan,
Michael R Klapal,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle M Noe,
Monique C Lo,
Mra Davism,
Myriam M Sosa,
Nailing Zhang,
Neal L Adams,
Nebil A Oumer,
Nicholas A Violand,
Nicholas L Paulin,
Noreen Muniz,
Noreen Muñiz,
Omotunde O Osunsanmi,
Pamela L Ogonowski,
Paraluman S Leonin,
Paranthaman Senthamaraikannan,
Patrick C Klotzbuecher,
Paula A Trost,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Priscilla M Pastrana,
Qin Xu,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Rodriguez,
Regina T Brown,
Richard H Penta,
Richard W Thornton,
Robert J Martin,
Roger F Zabinski,
Rose Xu,
Samantha J Bradley,
Samina S Khan,
Sandra P White,
Santiago Gallardo Johnson,
Sean R Marcsisin,
Seth A Mailhot,
Sharmista Chatterjee,
Shawn E Larson,
Shirley S Wen,
Sneha S Patel,
Stacey S Degarmo,
Steven Fong, MS, PhD,
Steven P Eastham,
Susan M Jackson,
Susant Hadman,
Tarun D Mehta,
Thomas J Arista,
Tonia F Bernard,
Tracey L Harris,
Travis S Bradley,
Uttaniti Limchumroon (Tom),
Victor J Gangi,
Vilmary Negron Rodriguez,
Vioela J Caze,
Virginia Carroll, PhD,
Walter Lange,
Wayne E Seifert,
Wen Ning Chan (Sally),
Xiaohui Shen,
Xiaokuang Lai, PhD,
Yanming An, PhD,
Ying Zhang,
Yong Hu,
Zachary A Bogorad,
Zachary L Miller,
Zakaria I Ganiyu,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Christina Capacci Daniel, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2018 | FDA 483 | Alnylam Pharmaceuticals Inc. - Form 483, 2018-05-04 |
| May, 2018 | FDA 483 Response | Alnylam Pharmaceuticals Inc. - Form 483R, 2018-05-18 |
| February, 2016 | FDA 483 | Janssen Ortho LLC - Form 483, 2016-02-26 |
| August, 2013 | FDA 483 | Patheon Pharmaceuticals Inc. - Form 483, 2013-08-26 |
| February, 2016 | EIR | Janssen Ortho LLC - EIR, 2016-02-26 |
| September, 2017 | FDA 483 | Vertex Pharmaceuticals Incorporated - Form 483, 2017-09-07 |
| July, 2014 | FDA 483 | BORA PHARMACEUTICAL LABORATORIES INC. - Form 483, 2014-07-26 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more